title: An Overdose Antidote Goes Mainstream.
authors.affiliation: Keith Humphreys (knh@stanford.edu) is a career research scientist in the Veterans Health Administration and a professor of psychiatry and behavioral sciences in the Department of Psychiatry at Stanford School of Medicine, in California. Any opinions expressed in this article are the responsibility of the author and do not necessarily reflect the official positions of the Veterans Health Administration.
authors.forename: Keith
authors.initials: K
authors.lastname: Humphreys
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects*; D000931:Antidotes; D062787:Drug Overdose / Q000188:drug therapy*; D004335:Drug and Narcotic Control; D060731:Emergency Responders; D006801:Humans; D009270:Naloxone; D009292:Narcotic Antagonists; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000701:Analgesics, Opioid; D000931:Antidotes; D009292:Narcotic Antagonists; D009270:Naloxone
keywords: Access To Care; Legal/Regulatory Issues; Mental Health/Substance Abuse